|
Nicotine Dependence Market ForecastPublished by: Datamonitor Published: Apr. 1, 2009 - 286 Pages Table of Contents
AbstractIntroductionWith a considerable patient population and continued government focus on lowering national smoking rates, the nicotine dependence market represents a lucrative opportunity for pharmaceutical companies. With strong uptake since launch in 2006 of Pfizer's Chantix (varenicline), the seven major prescription nicotine dependence market was estimated to total $1.35 billion in 2008. Reasons to Purchase
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||